Literature DB >> 21792629

Open3DALIGN: an open-source software aimed at unsupervised ligand alignment.

Paolo Tosco1, Thomas Balle, Fereshteh Shiri.   

Abstract

An open-source, cross-platform software aimed at conformer generation and unsupervised rigid-body molecular alignment is presented. Different algorithms have been implemented to perform single and multi-conformation superimpositions on one or more templates. Alignments can be accomplished by matching pharmacophores, heavy atoms or a combination of the two. All methods have been successfully validated on eight comprehensive datasets previously gathered by Sutherland and co-workers. High computational performance has been attained through efficient parallelization of the code. The unsupervised nature of the alignment algorithms, together with its scriptable interface, make Open3DALIGN an ideal component of high-throughput, automated cheminformatics workflows.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21792629     DOI: 10.1007/s10822-011-9462-9

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  18 in total

Review 1.  Computational methods for the structural alignment of molecules.

Authors:  C Lemmen; T Lengauer
Journal:  J Comput Aided Mol Des       Date:  2000-03       Impact factor: 3.686

Review 2.  Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.

Authors:  Osman Güner; Omoshile Clement; Yasuhisa Kurogi
Journal:  Curr Med Chem       Date:  2004-11       Impact factor: 4.530

3.  Open3DQSAR: a new open-source software aimed at high-throughput chemometric analysis of molecular interaction fields.

Authors:  Paolo Tosco; Thomas Balle
Journal:  J Mol Model       Date:  2010-04-11       Impact factor: 1.810

4.  Comparative performance assessment of the conformational model generators omega and catalyst: a large-scale survey on the retrieval of protein-bound ligand conformations.

Authors:  Johannes Kirchmair; Gerhard Wolber; Christian Laggner; Thierry Langer
Journal:  J Chem Inf Model       Date:  2006 Jul-Aug       Impact factor: 4.956

5.  BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. II. Description and characterization.

Authors:  Toni Rönkkö; Anu J Tervo; Jussi Parkkinen; Antti Poso
Journal:  J Comput Aided Mol Des       Date:  2006-07-20       Impact factor: 3.686

6.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.

Authors:  Steven L Dixon; Alexander M Smondyrev; Eric H Knoll; Shashidhar N Rao; David E Shaw; Richard A Friesner
Journal:  J Comput Aided Mol Des       Date:  2006-11-24       Impact factor: 3.686

7.  ShaEP: molecular overlay based on shape and electrostatic potential.

Authors:  Mikko J Vainio; J Santeri Puranen; Mark S Johnson
Journal:  J Chem Inf Model       Date:  2009-02       Impact factor: 4.956

Review 8.  Three-dimensional pharmacophore methods in drug discovery.

Authors:  Andrew R Leach; Valerie J Gillet; Richard A Lewis; Robin Taylor
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

9.  SDF2XYZ2SDF: how to exploit TINKER power in cheminformatics projects.

Authors:  Paolo Tosco; Thomas Balle; Fereshteh Shiri
Journal:  J Mol Model       Date:  2011-05-15       Impact factor: 1.810

10.  The Blue Obelisk-interoperability in chemical informatics.

Authors:  Rajarshi Guha; Michael T Howard; Geoffrey R Hutchison; Peter Murray-Rust; Henry Rzepa; Christoph Steinbeck; Jörg Wegner; Egon L Willighagen
Journal:  J Chem Inf Model       Date:  2006 May-Jun       Impact factor: 4.956

View more
  16 in total

1.  Insights into the interaction and binding mode of a set of antifungal azoles as inhibitors of potential fungal enzyme-based targets.

Authors:  Camilo Guerrero-Perilla; Freddy A Bernal; Ericsson Coy-Barrera
Journal:  Mol Divers       Date:  2018-06-29       Impact factor: 2.943

2.  SDF2XYZ2SDF: how to exploit TINKER power in cheminformatics projects.

Authors:  Paolo Tosco; Thomas Balle; Fereshteh Shiri
Journal:  J Mol Model       Date:  2011-05-15       Impact factor: 1.810

3.  Optimal affinity ranking for automated virtual screening validated in prospective D3R grand challenges.

Authors:  Bentley M Wingert; Rick Oerlemans; Carlos J Camacho
Journal:  J Comput Aided Mol Des       Date:  2017-09-16       Impact factor: 3.686

4.  Improved pose and affinity predictions using different protocols tailored on the basis of data availability.

Authors:  Philip Prathipati; Chioko Nagao; Shandar Ahmad; Kenji Mizuguchi
Journal:  J Comput Aided Mol Des       Date:  2016-10-06       Impact factor: 3.686

5.  MolAlign: an algorithm for aligning multiple small molecules.

Authors:  Shek Ling Chan
Journal:  J Comput Aided Mol Des       Date:  2017-06-01       Impact factor: 3.686

6.  Fragment oriented molecular shapes.

Authors:  Ethan Hain; Carlos J Camacho; David Ryan Koes
Journal:  J Mol Graph Model       Date:  2016-04-02       Impact factor: 2.518

7.  Optimal strategies for virtual screening of induced-fit and flexible target in the 2015 D3R Grand Challenge.

Authors:  Zhaofeng Ye; Matthew P Baumgartner; Bentley M Wingert; Carlos J Camacho
Journal:  J Comput Aided Mol Des       Date:  2016-08-29       Impact factor: 3.686

8.  BCL::MolAlign: Three-Dimensional Small Molecule Alignment for Pharmacophore Mapping.

Authors:  Benjamin P Brown; Jeffrey Mendenhall; Jens Meiler
Journal:  J Chem Inf Model       Date:  2019-02-12       Impact factor: 4.956

9.  Choosing the Optimal Rigid Receptor for Docking and Scoring in the CSAR 2013/2014 Experiment.

Authors:  Matthew P Baumgartner; Carlos J Camacho
Journal:  J Chem Inf Model       Date:  2015-08-07       Impact factor: 4.956

10.  QSAR analysis of immune recognition for triazine herbicides based on immunoassay data for polyclonal and monoclonal antibodies.

Authors:  Andrey A Buglak; Anatoly V Zherdev; Hong-Tao Lei; Boris B Dzantiev
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.